Aishwary Tukaram Shivgan

Aishwary Tukaram Shivgan

Auto-generated profile, based on publicly available information

Aishwary Tukaram Shivgan

National University of Singapore, Department of Biological Sciences, 14 Science Drive 4, Singapore 117543, Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2021 in Biochemistry
Verified
Journal Article
Open access
JAJoel D. Allen
Joel D. Allen
HCHimanshi Chawla
Himanshi Chawla
FSFirdaus Samsudin
Firdaus Samsudin
LZLorena Zuzic
Lorena Zuzic
ASAishwary Tukaram Shivgan
Aishwary Tukaram Shivgan
MCMax Crispin
Max Crispin
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike protein is a potential source of heterogeneity among the many different vaccine candidates under investigation. Here, we investigate the glycosylation of recombinant SARS-CoV-2 spike proteins from five different laboratories and compare them against S protein from infectious virus, cultured in Vero cells. We find patterns that are conserved across all samples, and this can be associated with site-specific stalling of glycan maturation that acts as a highly sensitive reporter of protein structure. Molecular dynamics simulations of a fully glycosylated spike support a model of steric restrictions that shape enzymatic processing of the glycans. These results suggest that recombinant spike-based SARS-CoV-2 immunogen glycosylation reproducibly recapitulates signatures of viral glycosylation.

3 June 2022 in Structure
Verified
Journal Article
Closed access
LZLorena Zuzic
Lorena Zuzic
FSFirdaus Samsudin
Firdaus Samsudin
ASAishwary T. Shivgan
Aishwary T. Shivgan
PRPalur V. Raghuvamsi
Palur V. Raghuvamsi
JMJan K. Marzinek
Jan K. Marzinek
PBPeter Bond
Peter Bond

9 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJoel D. Allen
Joel D. Allen
HCHimanshi Chawla
Himanshi Chawla
FSFirdaus Samsudin
Firdaus Samsudin
LZLorena Zuzic
Lorena Zuzic
ASAishwary Tukaram Shivgan
Aishwary Tukaram Shivgan
MCMax Crispin
Max Crispin
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike protein is a potential source of heterogeneity between the many different vaccine candidates under investigation. Here, we investigate the glycosylation of recombinant SARS-CoV-2 spike proteins from five different laboratories and compare them against infectious virus S protein. We find patterns which are conserved across all samples and this can be associated with site-specific stalling of glycan maturation which act as a highly sensitive reporter of protein structure. Molecular dynamics (MD) simulations of a fully glycosylated spike support s a model of steric restrictions that shape enzymatic processing of the glycans. These results suggest that recombinant spike-based SARS-CoV-2 immunogen glycosylation reproducibly recapitulates signatures of viral glycosylation.

15 February 2024 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
ASAishwary T. Shivgan
Aishwary T. Shivgan
JMJan K. Marzinek
Jan K. Marzinek
AKAlexander Krah
Alexander Krah
PMPaul Matsudaira
Paul Matsudaira
CVChandra S Verma
Chandra S Verma
PBPeter Bond
Peter Bond